JP6329553B2 - Ｉｂｓの診断マーカーとしての微生物バイオームに対する抗体、ストレス因子及びマスト細胞マーカー - Google Patents

Ｉｂｓの診断マーカーとしての微生物バイオームに対する抗体、ストレス因子及びマスト細胞マーカー Download PDF

Info

Publication number
JP6329553B2
JP6329553B2 JP2015535149A JP2015535149A JP6329553B2 JP 6329553 B2 JP6329553 B2 JP 6329553B2 JP 2015535149 A JP2015535149 A JP 2015535149A JP 2015535149 A JP2015535149 A JP 2015535149A JP 6329553 B2 JP6329553 B2 JP 6329553B2
Authority
JP
Japan
Prior art keywords
ibs
bacterial antigen
antibody
level
markers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2015535149A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015533213A (ja
JP2015533213A5 (https=
Inventor
シャラット シン，
シャラット シン，
リン， ニコラス チ‐クワン
リン， ニコラス チ‐クワン
シュイ‐ロン ワン，
シュイ‐ロン ワン，
フレッド プリンセン，
フレッド プリンセン，
ステファン ウェスティン，
ステファン ウェスティン，
スティーブン ロックトン，
スティーブン ロックトン，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Original Assignee
Nestec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec SA filed Critical Nestec SA
Publication of JP2015533213A publication Critical patent/JP2015533213A/ja
Publication of JP2015533213A5 publication Critical patent/JP2015533213A5/ja
Application granted granted Critical
Publication of JP6329553B2 publication Critical patent/JP6329553B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2015535149A 2012-10-05 2013-10-01 Ｉｂｓの診断マーカーとしての微生物バイオームに対する抗体、ストレス因子及びマスト細胞マーカー Expired - Fee Related JP6329553B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261710574P 2012-10-05 2012-10-05
US61/710,574 2012-10-05
US201361871853P 2013-08-29 2013-08-29
US61/871,853 2013-08-29
PCT/IB2013/059045 WO2014053996A2 (en) 2012-10-05 2013-10-01 Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for ibs

Publications (3)

Publication Number Publication Date
JP2015533213A JP2015533213A (ja) 2015-11-19
JP2015533213A5 JP2015533213A5 (https=) 2016-11-24
JP6329553B2 true JP6329553B2 (ja) 2018-05-23

Family

ID=49447585

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015535149A Expired - Fee Related JP6329553B2 (ja) 2012-10-05 2013-10-01 Ｉｂｓの診断マーカーとしての微生物バイオームに対する抗体、ストレス因子及びマスト細胞マーカー

Country Status (9)

Country Link
US (1) US10184940B2 (https=)
EP (1) EP2904395B1 (https=)
JP (1) JP6329553B2 (https=)
CN (1) CN104884959B (https=)
AU (1) AU2013326133B2 (https=)
CA (1) CA2886991A1 (https=)
MX (1) MX360479B (https=)
SG (2) SG11201502641YA (https=)
WO (1) WO2014053996A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0720250D0 (en) * 2007-10-17 2007-11-28 Univ Edinburgh Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof
BR112015027591A2 (pt) * 2013-05-17 2017-07-25 Basf Se processos para a preparação de um ácido, de um cloreto e de um composto de sulfimina
SG11201509371XA (en) * 2013-05-24 2015-12-30 Nestec Sa Pathway specific markers for diagnosing irritable bowel syndrome
AU2016349703A1 (en) 2015-11-06 2018-11-01 Vetica Labs, Inc. Methods of detecting inflammatory markers and treating inflammatory conditions in companion animals
EP3421616A1 (en) * 2017-06-29 2019-01-02 Tata Consultancy Services Limited Method and system for monitoring the gut health of an individual
AU2018346255A1 (en) * 2017-10-03 2020-04-23 Seres Therapeutics, Inc. Manipulation of tryptamine metabolism
JP6533930B1 (ja) * 2018-08-23 2019-06-26 一般社団法人日本農業フロンティア開発機構 疾病評価指標算出方法、装置、システム、及び、プログラム、並びに、疾病評価指標を算出するためのモデル作成方法。
US11884958B2 (en) 2019-04-30 2024-01-30 Mayo Foundation For Medical Education And Research Assessing and treating functional gastrointestinal disorders
WO2025071560A1 (en) * 2023-09-28 2025-04-03 Rutgers, The State University Of New Jersey Methods of diagnosing b cell malignancies, detecting b cell malignancy relapse, and treating thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004048600A2 (en) * 2002-11-22 2004-06-10 Emory University Diagnostic tests and methods for diagnosing inflammatory bowel disease
US20060154276A1 (en) * 2004-05-13 2006-07-13 Prometheus Laboratories Inc. Methods of diagnosing inflammatory bowel disease
US7943328B1 (en) * 2006-03-03 2011-05-17 Prometheus Laboratories Inc. Method and system for assisting in diagnosing irritable bowel syndrome
US20100094560A1 (en) * 2006-08-15 2010-04-15 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
US20080085524A1 (en) 2006-08-15 2008-04-10 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
CN102480932B (zh) * 2009-09-01 2015-01-14 阿昂梅迪克斯公司 源于肠道共生细菌的细胞外小泡及利用其的疫苗、备选药物筛选方法
PH12012500850A1 (en) * 2009-10-30 2013-01-07 Prometheus Laboratories Inc Methods for diagnosing irritable bowel syndrome

Also Published As

Publication number Publication date
CA2886991A1 (en) 2014-04-10
CN104884959B (zh) 2017-12-01
JP2015533213A (ja) 2015-11-19
MX2015004271A (es) 2015-08-14
WO2014053996A3 (en) 2014-05-30
EP2904395A2 (en) 2015-08-12
US20150346200A1 (en) 2015-12-03
WO2014053996A2 (en) 2014-04-10
CN104884959A (zh) 2015-09-02
SG10201702773QA (en) 2017-06-29
HK1213050A1 (en) 2016-06-24
EP2904395B1 (en) 2018-09-05
MX360479B (es) 2018-11-05
AU2013326133B2 (en) 2019-07-04
AU2013326133A1 (en) 2015-04-23
US10184940B2 (en) 2019-01-22
SG11201502641YA (en) 2015-05-28

Similar Documents

Publication Publication Date Title
JP6329553B2 (ja) Ｉｂｓの診断マーカーとしての微生物バイオームに対する抗体、ストレス因子及びマスト細胞マーカー
US10338083B2 (en) Pathway specific markers for diagnosing irritable bowel syndrome
JP2022528466A (ja) 疾患を診断する方法
JP6784669B2 (ja) 炎症性腸疾患及びセリアック病から過敏性腸症候群を識別するための方法及びシステム
Thieu et al. An evaluation of purified Salmonella Typhi protein antigens for the serological diagnosis of acute typhoid fever
van Thiel et al. Fungal feelings in the irritable bowel syndrome: the intestinal mycobiome and abdominal pain
Al-Karawi et al. Correlation between H. pylori infection and serum levels of inflammatory markers: A retrospective study
JP6193976B2 (ja) バイオマーカーとしてのクロストリジウム・ディフィシル（Ｃｌｏｓｔｒｉｄｉｕｍｄｉｆｆｉｃｉｌｅ）・デヒドロゲナーゼおよび毒素
Juzlova et al. Gastrointestinal comorbidities in patients with psoriasis in the Czech Republic: The results of 189 patients with psoriasis and 378 controls
CN105242045A (zh) 胃泌素-17作为具有增加的数种相关后发病风险的萎缩性胃炎的生物标志物的用途
Balaji et al. Helicobacter Pylori infection in systemic sclerosis and its association with upper gastrointestinal dysfunction
HK1213050B (en) Antibodies to microbiome as diagnostic markers for ibs
US20170212113A1 (en) Predictive value of clostridium difficile-specific immune response for recurrence and disease outcome
Ajamian Investigating Markers of Intestinal Barrier Dysfunction in Gastrointestinal Diseases
Minamoto Intestinal Microbiota and Its Functional Aspects in Dogs with Gastrointestinal Diseases
Piroozmand et al. Electronic Physician (ISSN: 2008-5842) http://www. ephysician. ir
WO2018130855A1 (en) Typhoid biomarkers
Breckan Helicobacter pylori infection in the 21st century

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161003

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161003

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170713

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170725

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20171024

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180122

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180327

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180420

R150 Certificate of patent or registration of utility model

Ref document number: 6329553

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees